Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Ardea Biosciences, Inc.    RDEA   US03969P1075

SummaryNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Income Statement Evolution
Ardea Biosciences, Inc. : Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 200920102011201220132014
Sales22,912,17,3110,710053,4
Operating income (EBITDA)--55,9-85,9-143-24,1-22,4
Operating profit (EBIT)-22,0-56,5-86,7-144-24,9-23,2
Pre-Tax Profit (EBT)---86,6---
Net income-30,9-41,6-86,6---
EPS ( $)-1,70-1,91-3,26-3,97-0,61-0,50
Dividend per Share ( $)------
Yield------
Announcement Date03/12/2010
09:00am
03/11/2011
01:30pm
03/09/2012
01:30pm
---
Finances - Leverage
Ardea Biosciences, Inc. : Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 200920102011201220132014
Debt------
Finance---31,222,945,2
Operating income (EBITDA)--55,9-85,9-143-24,1-22,4
Leverage
(Debt/EBITDA)
------
Capital Expenditure-0,561,461,501,581,65
Book Value Per Share (BVPS)---2,98 $2,47 $2,07 $
Cash Flow per Share--2,25 $-2,26 $-3,95 $-0,59 $-0,48 $
Announcement Date03/12/2010
09:00am
03/11/2011
01:30pm
03/09/2012
01:30pm
---
Assessed data source :
© 2013 Thomson Reuters
Advertisement
Financial Ratios

Size 2012e 2013e
Capitalization 1 178 M$ -
Company Value 1 147 M$ 1 155 M$
Valuation 2012e 2013e
PER (Price / EPS)
Capitalization / Revenue 110x 11,8x
EV / Revenue 107x 11,6x
EV / EBITDA -8,03x -48,0x
Yield (DPS / Price) - -
Profitability 2012e 2013e
Operating Margin (EBIT / Sales) -1 345% -24,9%
operating laverage (Delta EBIT / Delta Sales) - 0,10x
Net Margin (Net Profit / Revenue) - -
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) -151% -23,4%
Rate of Dividend - -
Balance Sheet Analysis 2012e 2013e
CAPEX / Sales   14,0% 1,58%
Cash Flow / Sales (Taux d'autofinancement) -1 363% -21,7%
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) 0,22x 0,95x
EPS & Dividend
Ardea Biosciences, Inc. : EPS Dividend
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.